Abstract
Group B Streptococcus (GBS) β C protein elicits protective antibodies in experimental animals, making β C protein an attractive component of a human GBS glycoconjugate vaccine. We determined whether natural exposure to β C protein elicits antibodies in humans. Geometric mean concentrations (in micrograms per milliliter) of β C-specific immunoglobulin (Ig) M and IgG as determined by enzyme-linked immunosorbent assay were similar in serum from 16 colonized (0.82 and 0.76, respectively) and 48 age-matched noncolonized (0.96 and 0.74, respectively) pregnant women. Serum from 3 women with β C GBS bacteremia had significantly higher levels of IgM (6.0) and IgG (52.9) (P = .01 and 0.01, respectively). Invasive disease but not colonization elicits β C-specific IgM and IgG. © 2006 by the Infectious Diseases Society of America. All rights reserved.
Cite
CITATION STYLE
Pannaraj, P. S., Kelly, J. K., Madoff, L. C., Ranch, M. A., Lachenauer, C. S., Edwards, M. S., & Baker, C. J. (2007). Group B Streptococcus bacteremia elicits β C protein-specific IgM and IgG in humans. Journal of Infectious Diseases, 195(3), 353–356. https://doi.org/10.1086/510627
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.